KP Tissue Inc

This company produces paper towels and other paper products. The rising cost for pulp has hurt their bottom line. China is buying more pure pulp fibre and this is hurting their business. Yield 7.4%. (Analysts’ price target is $11.00)

Consumer staples. He was taking a look at it when it pulled back He stayed away because the chart is telling him there is no clarity on share price given that input costs are on the rise. It is too early to buy.

It is a slow steady eddie company. It is okay and there is nothing wrong with it but it does not get him excited. It is probably not going to hurt your portfolio nor help it much.

The tissue space in general is struggling with pricing, probably as a result of over pricing in North America. Having a pure play in this area is not something you would want to do. Expects it will be challenged for the next couple of quarters. Prefers Cascades (CAS-T), which has an offset with container board/cardboard packaging.

As a hold for the next 5 years?On a total return basis, this is not as terrible as the stock price suggests. It has underperformed. There has always been something that pops up to hurt them over the past few years. It looks like pulp prices continue to go higher, so he doesn’t expect the best quarter in Q3. However, they have pricing power because their branded tissue toilet paper has been able to pass those price increases on to customers. He likes this for the 4.7% dividend. They have ambitious growth plans.

There are some certainties in life, and one of them is toilet paper. They are going to commission a new machine at their plant in Memphis Tennessee, which will increase output. It’s a competitive business. They do private label branding for the big box stores. Thinks earnings will come up and distribution will come up. Dividend yield of 4.8%.

Trading like it is a private label company, which is not the case, because they have significant branded products they sell in Canada. The previous quarter they had was pretty good, and have announced that they are raising prices. They are looking to add another private label machine and has also started another private label machine in Québec, which should improve margins. The knock against the company is that it is always next year’s story. 5% dividend yield.

The largest branded tissue manufacturer in Canada. Also, sells private label in the US. Trying to increase its private label exposure in the US and hopes to launch another tissue plant. These are all going to take time, money and effort. In the meantime, the stock has done absolutely nothing. On the flipside, you have a terrific dividend of almost 5%. They are investing for the future, which is not a bad thing. You are going to have to be patient. It is cheap on a valuation standpoint, but does have more debt than he would like.

He has been continuing to buy this for new and existing customers. He has now reached the limit of his weighting. Only 15% of the company’s stock has been sold to shareholders. This is a well run product with very strong pricing power and a nice dividend. They are working through a lot of projects including one to get more sales to offices.